Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jocelyn Contreras-Carmona
The Cellular Pathways of Liver Fibrosis in NASH
Related publications
Sorafenib Prevents Liver Fibrosis in a Non-Alcoholic Steatohepatitis (NASH) Rodent Model
Brazilian Journal of Medical and Biological Research
Immunology
Cell Biology
Pharmacology
Biochemistry
Biophysics
Neuroscience
Medicine
Toxicology
Physiology
Pharmaceutics
Plasma Lipidomics Distinguishes NASH and Fibrosis From Simple Fatty Liver in Children
The Roles of Gap Junctional Intercellular Communication in Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Metabolic Regulation of Hepatic PNPLA3 Expression and Severity of Liver Fibrosis in Patients With NASH
Liver International
Hepatology
C-Met Signaling Protects From Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types
Oxidative Medicine and Cellular Longevity
Biochemistry
Medicine
Cell Biology
Aging
Can Transient Elastography Be a Reliable Method for Assessing Liver Fibrosis in Non Alcoholic Steatohepatitis (NASH)?
Medical Ultrasonography
Nuclear Medicine
Radiology
Ultrasound Technology
Acoustics
Ultrasonics
Radiological
Imaging
Complementary Vascular and Matrix Regulatory Pathways Underlie the Beneficial Mechanism of Action of Sorafenib in Liver Fibrosis
Hepatology
Medicine
Hepatology
Spatiotemporal Characterization of the Cellular and Molecular Contributors to Liver Fibrosis in a Murine Hepatotoxic-Injury Model
American Journal of Pathology
Forensic Medicine
Pathology
Reversibility of Liver Fibrosis
Clinics and Research in Hepatology and Gastroenterology
Hepatology
Gastroenterology